Glucopyranosyl lipid adjuvant enhances immune response to Ebola virus-like particle vaccine in mice.

MLA

Sunay, Melek M. E., et al. “Glucopyranosyl Lipid Adjuvant Enhances Immune Response to Ebola Virus-like Particle Vaccine in Mice.” Vaccine, vol. 37, no. 29, June 2019, pp. 3902–10. EBSCOhost, https://doi.org/10.1016/j.vaccine.2019.05.026.

APA

Sunay, M. M. E., Martins, K. A. O., Steffens, J. T., Gregory, M., Vantongeren, S. A., Van Hoeven, N., Garnes, P. G., & Bavari, S. (2019). Glucopyranosyl lipid adjuvant enhances immune response to Ebola virus-like particle vaccine in mice. Vaccine, 37(29), 3902–3910. https://doi.org/10.1016/j.vaccine.2019.05.026

Chicago

Sunay, Melek M.E., Karen A.O. Martins, Jesse T. Steffens, Melissa Gregory, Sean A. Vantongeren, Neal Van Hoeven, Preston G. Garnes, and Sina Bavari. 2019. “Glucopyranosyl Lipid Adjuvant Enhances Immune Response to Ebola Virus-like Particle Vaccine in Mice.” Vaccine 37 (29): 3902–10. doi:10.1016/j.vaccine.2019.05.026.